US Patent Issued to JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG on May 19 for "Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers" (German, Swiss Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,418, issued on May 19, was assigned to JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG (Wurzburg, Germany).

"Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers" was invented by Jorg Wischhusen (Wurzburg, Germany), Markus Haake (Estenfeld, Germany), Reinhard Dummer (Zurich, Switzerland), Matthias Mehling (Basel, Switzerland), Tina Schafer (Wurzburg, Germany) and Martina Selle (Wurzburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to uses of inhibitors of human Growth and Differentiation Factor 15 (GDF-15), and to combined uses of such inhibitors wi...